[Standards of treatment of the hepatitis C (June 2008)].
Halota
Waldemar
W
Juszczyk
Jacek
J
D000998:Antiviral Agents / Q000627:therapeutic use; D019091:Critical Pathways / Q000592:standards*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D017410:Practice Guidelines as Topic / Q000592:standards*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin